| 價格 | 詢價 |
| 包裝 | 1支 |
| 最小起訂量 | 1支 |
| 發(fā)貨地 | 湖北 |
| 更新日期 | 2026-07-08 |
| 中文名稱:MOR-1兔多抗 | 英文名稱:MOR-1 Rabbit Polyclonal Antibody |
| 品牌: EnkiLife | 產(chǎn)地: 中國 |
| 保存條件: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. | 產(chǎn)品類別: 抗體 |
| 是否進口: 否 | 用途: 科研 |
產(chǎn)品概述
產(chǎn)品性能
免疫原
產(chǎn)品應用
研究背景
This gene encodes one of at least three opioid receptors in humans; the mu opioid receptor (MOR). The MOR is the principal target of endogenous opioid peptides and opioid analgesic agents such as beta-endorphin and enkephalins. The MOR also has an important role in dependence to other drugs of abuse, such as nicotine, cocaine, and alcohol via its modulation of the dopamine system. The NM_001008503.2:c.118A>G allele has been associated with opioid and alcohol addiction and variations in pain sensitivity but evidence for it having a causal role is conflicting. Multiple transcript variants encoding different isoforms have been found for this gene. Though the canonical MOR belongs to the superfamily of 7-transmembrane-spanning G-protein-coupled receptors some isoforms of this gene have only 6 transmembrane domains. [provided by RefSeq, Oct 2013],function:Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Receptor for beta-endorphin.,online information:Mu opioid receptor entry,polymorphism:Variant Asp-40 does not show altered binding affinities for most opioid peptides and alkaloids tested, but it binds beta-endorphin, an endogenous opioid that activates the mu opioid receptor, approximately 3 times more tightly than the most common allelic form.,similarity:Belongs to the G-protein coupled receptor 1 family.,subunit:Forms a complex with G(alpha)z/i2 subunits and the RGSZ proteins, RGSZ17 and RGSZ20. The formation of this complex results in mu-opioid receptor desensitization. Interacts with RGSZ17 and RGSZ20.,
研究領域
Neuroactive ligand-receptor interaction;
| 成立日期 | 2024-08-02 (2年) | 注冊資本 | 271萬人民幣 |
| 員工人數(shù) | 10-50人 | 年營業(yè)額 | ¥ 100萬-300萬 |
| 主營行業(yè) | 生化試劑,抗體,細胞培養(yǎng),癌癥研究,細胞生物學 | 經(jīng)營模式 | 工廠,試劑,定制,服務 |
| 產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
|---|---|---|---|---|
| 詢價 |
碧云天生物技術有限公司
|
2026-07-28 | ||
| ¥3750 |
武漢艾美捷科技有限公司
|
2026-07-28 | ||
| ¥16800 |
VIP1年
|
上海撫生實業(yè)有限公司
|
2026-07-29 |